This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roffler, S. R. Articles by Yeh, M.-Y. Search for Related Content PubMed PubMed Citation Articles by Roffler, S. R. Articles by Yeh, M.-Y.

Therapy of Human Cervical Carcinoma with Monoclonal Antibody-Pseudomonas Exotoxin Conjugates¹

Institute of Biomedical Sciences, Academia Sinica [S. R. R., M-H. Y., B. M. C., E. T., M-Y. Y.], Cancer Research Laboratory, Department of Medical Research, Tri-Service General Hospital [M-H. Y., M-Y. Y.], and Department of Microbiology and Immunology, National Defense Medical Center [M-Y. Y.], Taipei, Taiwan, Republic of China

Pseudomonas exotoxin A (PE) linked to the F(ab')₂ fragment of 1H10, a murine monoclonal antibody recognizing a carbohydrate epitope of a glycoconjugate expressed on the surface of human cervical carcinoma tumor cells, was evaluated for in vitro and in vivo activity. PE can kill cells by ADP-ribosylating elongation factor 2 thus inhibiting protein synthesis. Disulfide- as well as thioether-linked immunotoxins (1H10-PE) killed cervical carcinoma cells in vitro and were 20–160 times more inhibitory to target than to control cells. Cell killing was antibody mediated as demonstrated by the reduction of 1H10-PE growth inhibition to target CaSki cells by free 1H10 F(ab')₂. In addition, a control antibody immunotoxin was nontoxic to CaSki cells. Thioether-linked 1H10-PE administered either i.v. or i.p. suppressed the growth of established solid s.c. cervical carcinoma tumors xenografted in nude mice for over 30 days. Treatment with antibody alone or a control immunotoxin had no significant effect on tumor growth. Administration of immunotoxin i.p. was associated with less toxicity than administration i.v., but i.v. injections were more effective at suppressing the growth of established solid tumors.

¹ Supported by National Science Council Grants 78-0418-B016-01H and 79-0418-B016-01, Department of Health and Academia Sinica, Republic of China.

² To whom requests for reprints should be addressed, at Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China.

Received 2/ 5/91. Accepted 5/22/91.

This article has been cited by other articles:

				X.-M. Wang and S.-J. Huang The selective cytotoxicity of cobra venom factor immunoconjugate on cultured human nasopharyngeal carcinoma cell line Human and Experimental Toxicology, February 1, 1999; 18(2): 71 - 76. [Abstract] [PDF]

				B. T. Foley, J. M. Moehring, and T. J. Moehring Mutations in the Elongation Factor 2 Gene Which Confer Resistance to Diphtheria Toxin and Pseudomonas Exotoxin A J. Biol. Chem., September 29, 1995; 270(39): 23218 - 23225. [Abstract] [Full Text] [PDF]